• Publications
  • Influence
Heparin-induced thrombocytopenia.
BACKGROUND AND OBJECTIVE There are two types of heparin-induced thrombocytopenia (HIT). HIT I is characterized by a transitory, slight and asymptomatic reduction in platelet count, occurring in theExpand
  • 698
  • 44
  • PDF
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.
In contrast with extensive documentation in patients treated with unfractionated heparin (UFH), the incidence of heparin-induced thrombocytopenia (HIT) in medical patients receivingExpand
  • 187
  • 9
  • PDF
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.
Although heparin-induced thrombocytopenia (HIT) is a known complication of intravenous unfractionated heparin (UFH), its incidence in medical patients treated with subcutaneous UFH is less wellExpand
  • 251
  • 8
  • PDF
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.
Essential thrombocythemia (ET) may occur in women of childbearing age. To investigate the risk of pregnancy complications, we studied 103 pregnancies that occurred in 62 women with ET. The 2-tailedExpand
  • 138
  • 8
  • PDF
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
Acquired thrombotic thrombocytopenic purpura (TTP) is often due to anti-ADAMTS13 antibodies that inhibit the proteolytic activity of the plasma metallo-protease and/or accelerate its clearance.Expand
  • 206
  • 7
  • PDF
Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease
MYH9‐related disease (MYH9‐RD) is a rare autosomal‐dominant disorder caused by mutations in MYH9, the gene for the heavy chain of nonmuscle myosin IIA (NMMHC‐IIA). All patients present from birthExpand
  • 157
  • 7
  • PDF
Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications--a review.
OBJECTIVE This review of heparin-induced thrombocytopenia (HIT), the most frequent and dangerous side effect of heparin exposure, covers the epidemiology, pathophysiology, clinical presentation,Expand
  • 60
  • 6
Myocardial Infarction and Other Arterial Occlusions in Hemophilia A Patients
Myocardial infarction and other arterial occlusions are considered to be rare in hemophilia A. However, a systematic study of the subject has never been attempted. All case reports of myocardialExpand
  • 72
  • 5
Risk factors for early and late mortality in hospitalized older patients: the continuing importance of functional status.
BACKGROUND Prognostic information collected at hospital admission may be useful in defining care objectives and in deciding on therapy for older people. The aim of our study was to identify admissionExpand
  • 89
  • 5
  • PDF
Age as the major predictive factor of long‐term response to splenectomy in immune thrombocytopenic purpura
Sixty‐one consecutive patients undergoing splenectomy for chronic immune thrombocytopenia were retrospectively evaluated. Platelet response was considered as complete (CR) when platelet count rose toExpand
  • 77
  • 3